Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Lexaria Bioscience Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +3 vs. Q1 2026
- Shares held
- 1.64M
- +150.1K (+10.1%) vs. Q1 2026
- Total value
- $920.0K
- −$246.8K (−21.2%) vs. Q1 2026
- New holders
- 6
- 10 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3 | $2 | 0.00% | 00.0% | Unchanged |
| Gables Capital Management Inc. | 13 | $7 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 92 | $52 | 0.00% | +92 | New |
| Tower Research Capital LLC (TRC) | 152 | $85 | 0.00% | +150+7,500.0% | Added |
| Farther Finance Advisors, LLC | 172 | $96 | 0.00% | +6+3.6% | Added |
| FMR LLC | 213 | $119 | 0.00% | +213 | New |
| Federation des caisses Desjardins du Quebec | 382 | $214 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,195 | $1.23K | 0.00% | +1,590+262.8% | Added |
| Crews Bank & Trust | 3,864 | $2.16K | 0.00% | +3,864 | New |
| Royal Bank of Canada | 7,159 | $4.00K | 0.00% | +19+0.3% | Added |
| Vanguard Global Advisers, LLC | 10,204 | $5.71K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 14,033 | $7.86K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 15,189 | $8.51K | 0.00% | −7,811−34.0% | Reduced |
| Susquehanna International Group, LLP | 15,263 | $8.55K | 0.00% | +15,263 | New |
| Renaissance Technologies LLC | 16,500 | $9.24K | 0.00% | +200+1.2% | Added |
| Virtu Financial LLC | 18,901 | $11.0K | 0.00% | +18,901 | New |
| XTX Topco Ltd | 22,298 | $12.5K | 0.00% | −2,769−11.0% | Reduced |
| Krilogy Financial LLC | 24,153 | $13.5K | 0.00% | +4,500+22.9% | Added |
| BlackRock, Inc. | 27,445 | $15.4K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 25,714 | $15.5K | 0.00% | +25,714 | New |
| State Street Corp | 39,301 | $22.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 39,825 | $22.3K | 0.00% | +21,436+116.6% | Added |
| UBS Group AG | 46,966 | $26.3K | 0.00% | −5,742−10.9% | Reduced |
| HRT Financial LP | 65,049 | $36.0K | 0.00% | +46,584+252.3% | Added |
| Vanguard Fiduciary Trust Co | 94,166 | $52.7K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 100,013 | $56.1K | 0.00% | −40,000−28.6% | Reduced |
| Citadel Advisors LLC | 156,945 | $87.9K | 0.00% | +143,432+1,061.4% | Added |
| Geode Capital Management, LLC | 250,415 | $140.3K | 0.00% | −43,742−14.9% | Reduced |
| Vanguard Capital Management LLC | 298,436 | $167.1K | 0.00% | +76,143+34.3% | Added |
| Invenomic Capital Management LP | 345,685 | $193.6K | 0.01% | −96,616−21.8% | Reduced |
| BCV Asset Management Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −489−100.0% | Sold out |